Neurologie and Rehabilitace

The medical center is at the forefront of research in neuromuscular disorders, with a particular focus on Acetylcholine Receptor Binding Antibody Seronegative Generalized Myasthenia Gravis (AChR-Ab seronegative gMG). This condition, characterized by muscle weakness and fatigue, is a complex autoimmune disorder that requires specialized care and innovative treatment approaches.

• Advanced therapeutic strategies for gMG
• Immunological mechanisms in neuromuscular diseases
• Patient-centered care models

Through rigorous clinical trials, the center is evaluating the efficacy of novel treatments such as efgartigimod IV, aiming to improve patient outcomes and quality of life. The research conducted here not only enhances our understanding of gMG but also contributes to the development of targeted therapies that address the specific needs of seronegative patients.